Heading into 2024, companies face elevated interest rates, weak liquidity and no appetite from lenders for highly-leveraged capital structures.
The partners will initially launch in two clinics in Texas, providing patients with ALS access to virtual-first specialty care providers, including respiratory therapists.
The companies will leverage Absci's AI-enabled Integrated Drug Creation platform and the pharma giant's oncology research and development expertise.
Dr. Michael Howell, chief clinical officer at Google, discusses Med-PaLM's evolution in 2023 and recommendations for regulators developing rules for AI use in healthcare.
An automotive manufacturer in Japan has transformed its speech-to-text mobile app to an audio recognition system to help alleviate barriers in communication.
The company's CEO said it is leaving the CMS program at the end of the year due to not seeing a clear path to profitability.
The gastrointestinal surgery-focused company will use the funds to advance its endoluminal robotics technology for minimally invasive procedures.
Rx Savings Finder allows Walgreens' pharmacy customers to access low-cost prescriptions by comparing the price of medications on third-party discount cards.
Wearable sensors provide physiological biomarkers, helping to determine reasons for an athlete's performance and the necessity of altering training to avoid injury.
The partners will leverage IBM’s foundation model technologies to help identify antibodies designed to target and neutralize various disease-causing agents or cells.
